Affluent Medical S.A. (AFME.PA)
Affluent Medical S.A. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Aix-en-Provence, FR. The stock last traded at $2.81, up 0.00% on the session, giving a market capitalisation of $110.4M. Its beta of 0.79 implies it has historically moved less than the broad market.
Affluent Medical S.A., a French enterprise, specializes in the creation of minimally invasive medical solutions designed to address cardiovascular and vascular conditions. Its product pipeline includes the Kardiozis technology, engineered to manage abdominal aortic aneurysms, alongside the Kalios and Epygon implants, which target mitral insufficiency. Additionally, the company offers the Artus implant, an advanced electromechanical artificial sphincter devised for the comprehensive treatment of severe urinary incontinence in both female and male patients. Established in 2011, its headquarters are situated in Aix-en-Provence, France.
Affluent Medical S.A. is most often compared with the following Healthcare names: